-
1
-
-
13844280406
-
Pediatric red cell disorders and pure red cell aplasia
-
Perkins SL. Pediatric red cell disorders and pure red cell aplasia. Am J Clin Pathol. 2004;122:S70-S86.
-
(2004)
Am J Clin Pathol
, vol.122
-
-
Perkins, S.L.1
-
2
-
-
0035830306
-
Oxazolidinone antibiotics
-
Diekema DJ, Jones RN. Oxazolidinone antibiotics. Lancet. 2001;358:1975-1982.
-
(2001)
Lancet
, vol.358
, pp. 1975-1982
-
-
Diekema, D.J.1
Jones, R.N.2
-
3
-
-
0035992065
-
Hematologic effects of linezolid: Summary of clinical experience
-
Gerson SL, Kaplan SL, Bruss JB, et al. Hematologic effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother. 2002;46:2723-2726.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 2723-2726
-
-
Gerson, S.L.1
Kaplan, S.L.2
Bruss, J.B.3
-
5
-
-
0024735032
-
Chloramphenicol toxicity: 25 years of research
-
Yunis AA. Chloramphenicol toxicity: 25 years of research. Am J Med. 1989;87:44N-48N.
-
(1989)
Am J Med
, vol.87
-
-
Yunis, A.A.1
-
6
-
-
0001322925
-
Sideroblastic anemia
-
In: Lee GR, Foerster J, Lukens J, et al. 9th ed. Philadelphia: Lea & Febiger
-
Bottomley SS. Sideroblastic anemia. In: Lee GR, Foerster J, Lukens J, et al. Wintrobe's Clinical Hematology. 9th ed. Philadelphia: Lea & Febiger; 1993:852-871.
-
(1993)
Wintrobe's Clinical Hematology
, pp. 852-871
-
-
Bottomley, S.S.1
-
7
-
-
0015987123
-
Effect of chloramphenicol on reticulocyte delta-aminolaevulinic acid synthetase in rabbits
-
Rosenberg A, Marcus O. Effect of chloramphenicol on reticulocyte delta-aminolaevulinic acid synthetase in rabbits. Br J Haematol. 1974;26:79-83.
-
(1974)
Br J Haematol
, vol.26
, pp. 79-83
-
-
Rosenberg, A.1
Marcus, O.2
-
8
-
-
0032781958
-
Chloramphenicolinduced mitochondrial dysfunction is associated with decreased transferrin receptor expression and ferritin synthesis in K562 cells and is unrelated to IRE-IRP interactions
-
Leiter LM, Thatte HS, Okafor C, et al. Chloramphenicolinduced mitochondrial dysfunction is associated with decreased transferrin receptor expression and ferritin synthesis in K562 cells and is unrelated to IRE-IRP interactions. J Cell Physiol. 1999;180:334-344.
-
(1999)
J Cell Physiol
, vol.180
, pp. 334-344
-
-
Leiter, L.M.1
Thatte, H.S.2
Okafor, C.3
-
9
-
-
28144446613
-
Mitochondrial toxicity associated with linezolid
-
Soriano A, Miro' O, Mensa J. Mitochondrial toxicity associated with linezolid. N Engl J Med. 2005;353:2305-2306.
-
(2005)
N Engl J Med
, vol.353
, pp. 2305-2306
-
-
Soriano, A.1
Miro, O.2
Mensa, J.3
-
10
-
-
0035857774
-
Linezolid and reversible myelosuppression
-
Green SL, Maddox JC, Huttenbach ED. Linezolid and reversible myelosuppression. JAMA. 2001;285:1291.
-
(2001)
JAMA
, vol.285
, pp. 1291
-
-
Green, S.L.1
Maddox, J.C.2
Huttenbach, E.D.3
-
11
-
-
0036137811
-
Linezolid-induced anemia and thrombocytopenia
-
Waldrep TW, Skiest DJ. Linezolid-induced anemia and thrombocytopenia. Pharmacotherapy. 2002;22:109-112.
-
(2002)
Pharmacotherapy
, vol.22
, pp. 109-112
-
-
Waldrep, T.W.1
Skiest, D.J.2
-
12
-
-
0036680509
-
Linezolid-induced pancytopenia
-
Halpern M. Linezolid-induced pancytopenia. Clin Infect Dis. 2002;35:347-348.
-
(2002)
Clin Infect Dis
, vol.35
, pp. 347-348
-
-
Halpern, M.1
-
13
-
-
0037380765
-
Mechanisms for linezolid-induced anemia and thrombocytopenia
-
Bernstein WB, Trotta RF, Rector JT, et al. Mechanisms for linezolid-induced anemia and thrombocytopenia. Ann Pharmacother. 2003;37:517-520.
-
(2003)
Ann Pharmacother
, vol.37
, pp. 517-520
-
-
Bernstein, W.B.1
Trotta, R.F.2
Rector, J.T.3
-
14
-
-
0347694491
-
Challenges with linezolid therapy and reversible pancytopenia
-
Nimeiri HS, Nemiary DS. Challenges with linezolid therapy and reversible pancytopenia. Ann Hematol. 2003;82:533.
-
(2003)
Ann Hematol
, vol.82
, pp. 533
-
-
Nimeiri, H.S.1
Nemiary, D.S.2
-
15
-
-
5144228188
-
Sideroblastic anemia due to linezolid in a patient with a left ventricular assist device
-
Montpeit MC, Shammo JL, Loew J, et al. Sideroblastic anemia due to linezolid in a patient with a left ventricular assist device. J Heart Lung Transplant. 2004;23:1119-1122.
-
(2004)
J Heart Lung Transplant
, vol.23
, pp. 1119-1122
-
-
Montpeit, M.C.1
Shammo, J.L.2
Loew, J.3
-
16
-
-
27644538945
-
Linezolid-induced dyserythrozpoiesis: Chloramphenicol toxicity revisited
-
DawsonMA, Davis A, Elliott P, et al. Linezolid-induced dyserythrozpoiesis: chloramphenicol toxicity revisited. Intern Med J. 2005;35:626-628.
-
(2005)
Intern Med J
, vol.35
, pp. 626-628
-
-
DawsonM.A. Davis, A.1
Elliott, P.2
-
17
-
-
6344231849
-
Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: A case-control study
-
Senneville E, Legout L, Valette M, et al. Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study. J Antimicrob Chemother. 2004;54:798-802.
-
(2004)
J Antimicrob Chemother
, vol.54
, pp. 798-802
-
-
Senneville, E.1
Legout, L.2
Valette, M.3
-
18
-
-
29244444185
-
High frequency of linezolidassociated thrombocytopenia and anemia among patients with end-stage renal disease
-
Wu VC,Wang YT,Wang CY, et al. High frequency of linezolidassociated thrombocytopenia and anemia among patients with end-stage renal disease. Clin Infect Dis. 2006;42:66-72.
-
(2006)
Clin Infect Dis
, vol.42
, pp. 66-72
-
-
Wu, V.C.1
Wang, Y.T.2
Wang, C.Y.3
-
19
-
-
0035019692
-
Pharmacia and Upjohn. Linezolid for the treatment of community-acquired pneumonia in hospitalized children
-
Linezolid Pediatric Pheumonia Study Group. Linezolid Pediatric Pneumonia Study Group
-
Kaplan SL, Patterson L, Edwards KM, et al; Linezolid Pediatric Pheumonia Study Group. Pharmacia and Upjohn. Linezolid for the treatment of community-acquired pneumonia in hospitalized children. Linezolid Pediatric Pneumonia Study Group. Pediatr Infect Dis J. 2001;20:488-494.
-
(2001)
Pediatr Infect Dis J
, vol.20
, pp. 488-494
-
-
Kaplan, S.L.1
Patterson, L.2
Edwards, K.M.3
|